12:00 AM
 | 
Oct 07, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Transkaryotic Therapies Inc.

(TKTX), Cambridge, Mass.

Business: Gene/Cell therapy, Hematology, Metabolic

SG Cowen analyst Eric Schmidt lowered his rating to "outperform" from "strong buy" after TKTX announced last week that third quarter European...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >